Greg Lovins
Analyst · Baird
Alright. Thanks Mitch and hello, everybody. I'll first provide some additional color on a performance against our long-term targets, and then walk you through fourth quarter performance and our outlook for 2022. As Mitch said, 2021 was an important milestone for the company as the final year for the five year financial targets we communicated in early 2017. And as he noted, we again achieved our companywide targets. The consistent execution of our key strategies enables us to continue delivering against our targets, with an overriding focus on delivering GDP plus growth in top quartile returns on capital over the long term. Over the five year period, sales growth on a constant currency basis was 6.6% annually, with an organic growth of 4.6% annually, both above our target. Our organic growth was roughly 2x global GDP for the same period. Operating margin was almost two full points above our target of 11%. And additionally, our EBITDA margin was above 15.6% in 2021, up almost three points compared to 2016. And adjusted EPS grew more than 17% annually over the past five years, significantly surpassing our target of 10%. And, as always, our focus continues to be the optimal balance of growth, margins and capital efficiency to drive incremental EVA over the long term. To that point, our return on total capital performance continues to be in the top quartile relative to our capital market peers coming in at over 18% in 2021, again above our target. And our balance sheet remained strong with our net debt to EBITDA ratio below the low end of our target range, giving us ample capacity to continue executing our strategies. Looking at the segments, both LGM and RBIS met or exceeded their organic growth targets and delivered margins above the high end of their target range. And we've made significant progress in IHM despite being short of our targets there. In March of last year, we also introduced a new set of long term targets for the company through 2025. Designed to continue delivering superior value creation over the long term. One year into this cycle, we are on track to achieve these goals as well. Given the diversity of our end markets, our strong competitive advantages and resilience as an organization to adjust course when needed, we're confident in our ability to continue delivering through a wide range of business cycles. Now let me provide some color on the fourth quarter. We delivered another strong quarter with adjusted earnings per share of $2.13 slightly above our expectation from a quarter ago, reflecting a tax benefit of a few cents and operational performance right in line with our midpoint Earnings were down 6% versus last year, given the extra week in the prior year, and up 23% compared to 2019, driven by significant revenue growth and solid margins. As expected, the impact of the extra week and belt tightening in Q4 of 2020 created tough comps. That combined with the increased pace of investments, and a net headwind from pricing and inflation in 2021, decrease margins in the fourth quarter. Sales were up 19% ex. currency and 13% on an organic basis compared to prior year, driven by higher prices and strong volume. As Mitch mentioned, our input costs have continued to rise and supply chains remain tight. We continue to address the cost increases through a combination of product reengineering and pricing, and have announced additional price increases in most of our businesses and regions around the world. Despite the impact of inflation and supply chain disruptions, we delivered a strong adjusted EBITDA margin of 14.9%, down compared to prior year and up 40 basis points compared to 2019. Turning to cash generation allocation, for the year we generated $798 million of free cash flow, up 46% compared to prior year, and 56% compared to 2019. And we invested $272 million in fixed capital and information technology, as we continue to accelerate investment in our high value categories, particularly RFID. And as mentioned previously, our balance sheet remained strong, with a net debt to adjusted EBITDA ratio at year end of 2.2. Our current leverage position gives us ample capacity to continue investing organically, as well as through strategic acquisitions while continue to return cash to shareholders in a disciplined way. During the year, we deployed $1.5 billion for acquisitions, as well as returned $400 million to shareholders through the combination of share repurchases and a growing dividend. Now, let me turn to the segment results for the quarter. Label and Graphic Material sales were up 12% ex. currency and 11% on an organic basis, driven by a high single digit impact from price and higher volume and mix. Growth remain strong in both the high value categories and a base business with both label and packaging materials and graphics and reflective sales up low double digits on an organic basis. Looking at the segment's organic sales growth in the quarter by region, North America sales were up mid-teens. And Western Europe sales were up high single digits despite raw material, labor and freight availability challenges that have continued to cause extended lead times for both of these regions. Overall, emerging market sales were up roughly 10% in the quarter with India and China both up double digits. And while LTM's profitability remained strong adjusted EBITDA margin decrease from last year to 14.5%, as the impact of raising prices reduced the margin by roughly 140 basis points, while the remainder of the decline coming from the impact of the extra week last year in the price cost lag mentioned previously. Shifting now to Retail Branding and Information Solutions. RBIS sales were up 39% ex. currency and 20% on an organic basis. As growth remained strong in both the high value categories and the base business. The apparel business saw particular strength and performance in premium channels and continued double digit growth in external embellishments. For the quarter, Intelligent Label sales were up more than 20% organically and adjusted EBITDA margin for the segment remained strong at 19%. With the positive benefits from acquisitions and higher volume were offset by growth investments, higher employee related costs and the headwind from prior year temporary cost reduction actions. Turning to the Industrial and Healthcare Material segment, sales increased 12% ex. currency and 10% on an organic basis, adjusted EBITDA margin decreased to 12.9%, which similar to LGM was driven by the impact of raising prices, the impact of the extra week last year and by the price cost timing lag. Now shifting to our outlook for 2022. We anticipate adjusted earnings per share to be in the range of $9.35 to $9.75. We've outlined some of the key contributing factors to this guidance on slide 19 of our supplemental presentation materials. We estimate that organic sales growth will be 8% to 11%, reflecting mid to high single digits from higher prices, and low to mid-single digit volume growth, coming up very strong volume growth across the segments in 2021. Based on current rates, currency translation is a roughly three point headwind to reported sales growth, with an estimated $35 million headwind to operating income. This is roughly $15 million worse than we would have expected a quarter ago, given recent changes in exchange rates. On inflation, our outlook assumes the low to mid-teens rate for the full year, with the largest impacts coming in the first half. And we anticipate spending up to $350 million in fixed capital and IT projects as we continue to increase our pace of investment, adding capabilities and new capacity, particularly in key strategic platforms. And we are also investing roughly $35 million in operating expense, principally in intelligent labels, digital capabilities, and sustainability. We expect our tax rate will be in the mid-20s for the full year based on current regulations as well. And lastly, we anticipate earnings growth in 2022 will be back half weighted due to tough comps in the first part of the year, particularly Q1, including the timing of currency headwinds, the price cost lag and the increasing pace of investments. In summary, through this dynamic environment, we are pleased with the strategic and financial progress we've made against our long-term goals in 2021. And we are confident in our ability to continue to deliver exceptional value through our strategies for long-term profitable growth and disciplined capital allocation. Now we'll open up the call for your questions.